David W Hillman

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Radical Prostatectomy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

Nature communications

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto A Leon-Ferre, Jodi M Carter, David Zahrieh, Jason P Sinnwell, Roberto Salgado, Vera J Suman, David W Hillman, Judy C Boughey, Krishna R Kalari, Fergus J Couch, James N Ingle, Maschenka Balkenhol, Francesco Ciompi, Jeroen van der Laak, Matthew P Goetz
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Roberto A Leon-Ferre, Jodi M Carter, David Zahrieh, Jason P Sinnwell, Roberto Salgado, Vera J Suman, David W Hillman, Judy C Boughey, Krishna R Kalari, Fergus J Couch, James N Ingle, Maschenka Balkenhol, Francesco Ciompi, Jeroen van der Laak, Matthew P Goetz
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, Brian C Miller, David W Hillman, Glenn Heller, Todd E Druley, Andrew J Armstrong, Michael J Morris, Matthew I Milowsky, Himisha Beltran, Kelly L Bolton, Catherine C Coombs
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Jodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W Hillman, Kathleen S Tenner, Jennifer M Kachergus, Heather Ann Brauer, Sarah E Warren, David Henderson, Ji Shi, Yi Liu, Heikki Joensuu, Henrik Lindman, Roberto A Leon-Ferre, Judy C Boughey, Minetta C Liu, James N Ingle, Krishna R Kalari, Fergus J Couch, Keith L Knutson, Matthew P Goetz, Edith A Perez, E Aubrey Thompson
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer. Nature communications 14 (1) (2023)
Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A Hoadley, Joel S Parker, Baljit Singh, Jordan D Campbell, Karla V Ballman, David W Hillman, Eric P Winer, Sarra El-Abed, Martine J Piccart, Serena Di Cosimo, William Fraser Symmans, Ian E Krop, Roberto Salgado, Sherene Loi, Lajos Pusztai, Charles M Perou, Lisa Anne Carey, Christos Sotiriou
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. Nature communications 14 (1) (2023)
Michael J Morris, Glenn Heller, David W Hillman, Olivia Bobek, Charles Ryan, Emmanuel S Antonarakis, Alan H Bryce, Olwen Hahn, Himisha Beltran, Andrew J Armstrong, Lawrence Schwartz, Lionel D Lewis, Jan H Beumer, Brooke Langevin, Eric C McGary, Paul T Mehan, Amir Goldkorn, Bruce J Roth, Han Xiao, Colleen Watt, Mary-Ellen Taplin, Susan Halabi, Eric J Small
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Brooke R Druliner, Krishna R Kalari, Sisi Qin, Scott M Dehm, Vipul Bhargava, Michael Gormley, Winston Tan, Jason P Sinnwell, David W Hillman, Ying Li, Peter T Vedell, Rachel E Carlson, Alan H Bryce, Raphael E Jimenez, Richard M Weinshilboum, Manish Kohli, Liewei Wang
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment. Molecular cancer research : MCR 20 (12) (2022)
Aranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, Mei-Yin C Polley, Joel S Parker, Lucas Huebner, Katherine A Hoadley, Jonathan Shepherd, Sara M Tolaney, Norah L Henry, Chau Dang, Lyndsay Harris, Donald A Berry, Olwen Hahn, Clifford A Hudis, Eric P Winer, Ann H Partridge, Charles M Perou, Lisa A Carey
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (35) (2020)